North Atlantic Life Insurance of America v. Katz
Cases that cite this one
8 later published cases cite this decision.
- Koczwara v. Nationwide General Insurance Company (District Court, S.D. New York 2022)
- Legawiec v. North American Company for Life & Health Insurance (Appellate Division of the Supreme Court of New York 2007)
- Curanovic v. New York Central Mutual Fire Insurance (Appellate Division of the Supreme Court of New York 2003)
- Hidary v. Maccabees Life Insurance (New York Supreme Court 1992)
- Selective Ins. Co. of N.Y. v. St. Catherine's Ctr. for Children (New York Supreme Court 2019)
- Dong Sheng Lu v. Equitable Co. (Appellate Division of the Supreme Court of New York 2004)
- Meagher v. Executive Life Insurance (Appellate Division of the Supreme Court of New York 1994)
- Schondorf v. SMA Life Assurance Co. (District Court, E.D. New York 1990)
This list shows which later cases cite this one. It does not say how they treated it, and no review of that has been done. Not a substitute for Shepard’s or KeyCite — verify before relying.
Opinion of the Court
In related actions (1) by the insurer the North Atlantic Life Insurance Company of America to rescind life insurance policy No. 176961 (action No. 1), and (2) by the named beneficiary to recover the face amount of that policy (action No. 2), the
Ordered that the order is reversed, on the law, with costs, the appellant’s motions for summary judgment are granted, life insurance policy No. 176961 is rescinded, and, upon searching the record, the complaint in action No. 2 is dismissed.
On May 30, 1985, the respondent’s decedent, Hyman Katz (hereinafter the decedent), submitted an application for a $1,000,000 life insurance policy to the North Atlantic Life Insurance Company of America (hereinafter North Atlantic). In "Part Two” of the application form, containing pertinent medical information, the decedent truthfully acknowledged, inter alia, that he had been treated for lymphoma in the early 1970’s. The $1,000,000 policy was issued on June 25, 1985. Shortly thereafter the decedent experienced a recurrence of lymphoma necessitating, inter alia, chemotherapy treatment. In early July 1985, North Atlantic solicited the decedent’s application for a second life insurance policy (No. 176961). Because the decedent had so recently completed the. "Part Two” medical information section of the application for the first policy, he was not required to complete "Part Two” in submitting his application for the second policy. The decedent did not disclose the recurrence of the lymphoma to North Atlantic in connection with his application for the latter policy. Instead, the decedent permitted his insurance agent to rely upon the information provided by him in "Part Two” of the first application in completing the second application on the decedent’s behalf. In addition, in completing the first part of the application the decedent provided a negative response to the question: "Has any person proposed for insurance * * * ever had life or health insurance declined, modified, rated or cancelled?” However, after issuing the second policy North Atlantic discovered that the decedent had obtained a $1,000,000 substandard or "rated” life insurance policy from Unity Mutual Life Insurance Company which carried higher premiums than those required for a standard policy.
An insured cannot remain silent while cognizant that his insurance application contains misleading or incorrect information (see, Axelroad v Metropolitan Life Ins. Co., 267 NY 437; Wageman v Metropolitan Life Ins. Co., 24 AD2d 67, affd 18 NY2d 777). In particular, he must notify his insurance company of nonapparent medical conditions which the com
Case-law data current through September 30, 2026. Source: CourtListener bulk data.